SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Direct costs attributable to producing goods sold
3Y CAGR
-1.7%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.13M | -34.7% |
| 2024 | $4.79M | +28.0% |
| 2023 | $3.75M | +13.8% |
| 2022 | $3.29M | +99.0% |
| 2021 | $1.65M | - |
| 2020 | $0.00 | - |
| 2019 | $0.00 | - |